Position in LLY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$183,953
-$15,936 QoQ
Shares Held
200
+7.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026S&T Bank/PA holds $5,949,719 across 10 Drug Manufacturers - General names. LLY ranks #4 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
21,548 | $4,686,474 | |
| 2 | JNJ |
Johnson & Johnson
|
2,263 | $553,167 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,564 | $188,133 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
200 | $183,953 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,916 | $116,204 | |
| 6 | AMGN |
Amgen Inc
|
299 | $105,202 | |
| 7 | NVO |
Novo Nordisk A S
|
1,430 | $52,552 | |
| 8 | PFE |
Pfizer Inc
|
1,314 | $36,896 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $183,953 | 200 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $199,889 | 186 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $108,346 | 142 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $114,590 | 147 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $125,538 | 152 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $101,132 | 131 | Shares | Other | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||